ZENLABS Stock View

Zenlabs Ethica Ltd
stock-view-header

icon 0.29 | 0.60
Market Cap ₹( Cr.)
314.04
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
28-May-2023
 

The average score for Zenlabs Ethica Ltd stands at 1 against 3, three months back.

Zenlabs Ethica Limited is an India-based marketing company. The Company is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. It has approximately five state-of-the-art manufacturing units. It operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations and other.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
56.05
100 DMA(₹)
55.53
200 DMA(₹)
60.87
52 Weeks Range
30.60     83.00